Are Testosterone Screening Thresholds Misleading Doctors?

Routine wellness checkups increasingly prompt healthy young men to request hormone profiling. However, interpreting testosterone screening thresholds without clinical signs can create considerable diagnostic confusion. A recent study in JAMA analyzed morning hormone measurements from active-duty military personnel. Consequently, the researchers highlighted how routine testing in healthy cohorts leads to substantial overdiagnosis.

Evaluating Testosterone Screening Thresholds in Clinical Practice

The JAMA investigation evaluated 479 active-duty service members using standard diagnostic cutoffs. Specifically, researchers found that 25.7 percent of soldiers fell below the 300 ng/dL threshold. Furthermore, nearly 15 percent scored below the more conservative 264 ng/dL benchmark. Older participants and individuals with higher body mass index demonstrated lower serum levels. Therefore, laboratory cutoffs alone do not reliably reflect actual endocrine pathology in healthy men. In fact, these findings closely mirror patterns seen in the general civilian population, which are frequently evaluated through structured general practice protocols.

Key Pitfalls of Universal Hormone Testing

Many commercial healthcare checkups promote unsolicited hormone panels to asymptomatic adults. However, total testosterone levels fluctuate widely throughout the day due to circadian variations. In addition, acute psychological stress, poor sleep, and illness transiently suppress gonadal production. Clinicians who rely on a single laboratory draw risk misclassifying healthy individuals as hypogonadal. As a result, premature testosterone replacement therapy can suppress endogenous spermatogenesis and impair fertility. Thus, medical practitioners must avoid mass testing without clear clinical indications.

Guideline Recommendations for Hypogonadism Diagnosis

Both the Endocrine Society and the American Urological Association provide clear diagnostic frameworks. First, clinicians must identify persistent, characteristic symptoms such as decreased libido or fatigue. Furthermore, laboratory confirmation requires at least two separate fasting morning total testosterone measurements. Doctors should also measure luteinizing hormone and follicle-stimulating hormone to pinpoint etiology. Moreover, treating physicians must prioritize lifestyle optimization and weight management for borderline cases, aligning with educational frameworks found in diabetes and endocrinology speciality courses. Consequently, accurate diagnosis safeguards patient health and prevents unwarranted lifelong hormone regimens.

Frequently Asked Questions

Q1: Why should clinicians avoid screening asymptomatic men for low testosterone?

Asymptomatic screening frequently detects transiently low hormone levels that lack clinical relevance. Therefore, testing asymptomatic patients leads to unnecessary medical anxiety and overtreatment.

Q2: How should physicians confirm a diagnosis of testosterone deficiency?

Diagnosis requires classic clinical symptoms alongside two separate low morning total testosterone measurements. Furthermore, clinicians must assess reversible lifestyle factors like obesity and sleep restriction.

Q3: What risks accompany unnecessary testosterone replacement therapy in young men?

Exogenous hormone administration suppresses the hypothalamic-pituitary-gonadal axis and impairs fertility. In addition, unwarranted therapy can provoke erythrocytosis, acne, and long-term testicular atrophy.

References

1. Hennigar SR et al. Testosterone Screening Thresholds in Active-Duty US Male Service Members. JAMA. 2026 Oct 15. doi: 10.1001/jama.2026.19794. PMID: 42879141.
2. American Urological Association. Identification and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018;200(2):423-432.
3. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744.